Metraipolis › archive › dc_4e6afef16e67
Recombinant RGD-Apoptins Decrease Human Melanoma Cell Viability — Europe PMC PMID:41465443
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41465443
- DOI
- 10.3390/ijms262412016
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T16:12:13.435Z
- SHA-256 of the archived text
ad6ca03d12534328d0808ed1ad4cfea283de14d7f1272375191f6dd99d237f5d- Stable URL of this page
https://metraipolis.com/documento/dc_4e6afef16e67
How to cite
Recombinant RGD-Apoptins Decrease Human Melanoma Cell Viability — Europe PMC PMID:41465443 — Europe PMC (en), https://europepmc.org/article/MED/41465443 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4e6afef16e67 (Metraipolis archive dc_4e6afef16e67, sha256 ad6ca03d12534328d0808ed1ad4cfea283de14d7f1272375191f6dd99d237f5d)
BibTeX
@misc{dc4e6afef16e67,
title = {Recombinant RGD-Apoptins Decrease Human Melanoma Cell Viability — Europe PMC PMID:41465443},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41465443},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4e6afef16e67; sha256 ad6ca03d12534328d0808ed1ad4cfea283de14d7f1272375191f6dd99d237f5d},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41465443. Agents can read the archived copy with the MCP tool read_document.